Pharma News

“Our new facility was built in response to increasing customer demand for our early-phase formulation development and clinical trial man...

Natural health medicine has the benefits in that it is one of the few medicines that have little or no side effects.

The South African Health Products Regulatory Authority (SAHPRA) has approved Cipla’s latest first-line triple-combination antiretroviral (ARV) treatment for HIV. The new combination medicine, commonly referred to as TLD, is a combination of tenofovir (TDF

A joint scientific study report by commissioned by the Ministry of Heavy Industries & Public Enterprises and conducted by The Energy Resources Institute (TERI) and the Automotive Research Association of India (ARAI) has said that strong policies are n

Clinical trials are expected to grow at a compound annual growth rate of 14 percent from 2014 to 2019, to reach an estimated value of $1,848.5 million

120-crore to set up this new production line, which will boost the capacity to manufacture liquid vials, injectables, eye drops and tabl...

One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum Asia's Top 20 list. The pharmaceutical giant recorded net profit of $1 billion for the fiscal year 2012, marking a growth of 4.5 percent f

Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing its product line with acquisitions that took place in 2012. The company strengthened its product base by launching new products such as A

Researchers have found that some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions about reimbursing cancer drugs following European Medicines Agency (EMA) approval.

Swiss pharmaceutical firm Novartis has signed a $2.1bn deal to acquire all outstanding shares of US-based biopharmaceutical company Endocyte in order to bolster its position in radiopharmaceuticals.

A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD). Researchers at the Westmead Institute for Medical Rese

Pity the poor deal banker, trying to pitch M&A ideas in a period of huge demand for biotech IPOs and while the sector is awash with financing options. Why would a young drug maker sell out to a bigger company in these circumstances, without a huge sum

Three researchers who “harnessed the power of evolution” to produce enzymes and antibodies that have led to a new best-selling drug and biofuels won the Nobel Prize in chemistry.

However, opportunities for CMOs and drug companies relating to non-opioid painkiller manufacture are likely to become more lucrative in ...

Amgevita, as the biosimilar is known, is the first such version of the world’s best-selling drug to secure approval from the European Commission, and as such is authorised for use in all the indications of its reference product, including moderate-to-seve

The Committee for Orphan Medicinal Products of the European Medicines Agency has now issued a positive opinion on orphan drug designation for POL6014, acknowledging “the needs of patients with cystic fibrosis” as well as the need for “a novel treatment ap

The Department of Pharmaceuticals (DoP) will soon initiate the process to select a financial institution for implementing the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) for small and medium enterprises.

DJSI is one of the most esteemed global benchmarks for sustainable business practices. Only the top ranked companies in terms of corporate sustainability within each industry are selected to be featured in the index.

The recently released draft guidelines for the online pharmacy industry have raised several questions for players operating in the burgeoning space, including on a possible overlapping role of state governments. The gazette notification, released on Augus

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the US FDA for Estradiol Vaginal Inserts USP, 10 mcg, the generic version of Vagifem1, 10 mcg, of Novo Nordisk Inc.According to IQVIA sales data for the 12-month period ending July 20